Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chemotherapy-induced
100%
In Vivo Antitumor Activity
100%
Homeodomain-interacting Protein Kinase 2 (HIPK2)
100%
Zinc Supplementation
100%
Zinc
57%
Adriamycin
57%
Tumor Suppression
42%
Pro-apoptotic
42%
Wild-type p53
28%
Mammary Tumor
28%
Overexpressing
14%
Tumor
14%
Tumor Growth in Vivo
14%
Positive Regulator
14%
Transgenic Mice
14%
Her2neu
14%
Combined Treatment
14%
Knockdown
14%
Histopathological Features
14%
Phosphorylation
14%
Misfolding
14%
Low Expression
14%
Human Cancer
14%
Tumor Suppressor Activity
14%
Sensitivity to Chemotherapy
14%
Puberty
14%
Cancer Model
14%
New Biomarkers
14%
Long Latency
14%
Combined Administration
14%
P53 Activity
14%
MMTV-Neu
14%
Transcriptional Repression
14%
Transcription Activity
14%
Tumor Aggressiveness
14%
Biochemistry, Genetics and Molecular Biology
P53
100%
Protein Kinase
100%
Homeodomain
100%
Doxorubicin
57%
Transcription
28%
Wild Type
28%
Zinc
28%
Conformation
14%
Tumor Suppressor Protein
14%
Serine
14%
Tumor Progression
14%
HER2/neu
14%
Cancer Model
14%
Transgenic Mouse
14%
Mouse Mammary Tumor Virus
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Protein P53
100%
Homeodomain Interacting Protein Kinase 2
100%
Doxorubicin
57%
Cancer Inhibition
42%
Neoplasm
14%
Tumor Growth
14%
Tumor Suppressor Protein
14%
Mouse Mammary Tumor Virus
14%
Transgenic Mouse
14%
Cancer Model
14%
Biological Marker
14%
Serine
14%
Neuroscience
In Vivo
100%
P53
100%
Homeodomain Interacting Protein Kinase 2
100%
Doxorubicin
57%
In Vitro
14%
Serine
14%
Tumor Suppressor Protein
14%
Cancer Model
14%
HER2/neu
14%